Opportunity
SAM #HT9426-27-NOI-049825
Sole-source purchase of two MP201 prodrug batches and research support
Buyer
Defense Health Agency
Posted
November 16, 2026
Respond By
December 31, 2026
Identifier
HT9426-27-NOI-049825
NAICS
541715, 325412
The Defense Health Agency plans to sole-source MP201 prodrug and related research support for Walter Reed Army Institute of Research studies. - Buyer: Defense Health Agency Contracting Activity, for WRAIR’s Center for Military Psychiatry and Neuroscience, Integrative Systems Biology Branch. - Sole-source supplier and product source: Mitochon Pharmaceuticals, Inc.; the notice describes MP201 as proprietary. - Products: Two freshly synthesized batches of MP201 (part number MP201), for oral administration and mouse dosage testing at approximately 8–80 mg/kg body weight. - Related support: Quality-control documentation, dosage background information, and assistance preparing research reports and manuscripts. - Timing and value: The provided notice does not specify a performance period or estimated contract value.
Description
See Attachment. Notice of Intent to Sole Source - M201 ProDrug_Approved for posting 16NOV26